Related Experiment Video
Updated: May 27, 2026

08:50
Predictive Immune Modeling of Solid Tumors
Published on: February 25, 2020
A mathematical model of tumor-immune interactions
Mark Robertson-Tessi1, Ardith El-Kareh, Alain Goriely
1Program in Applied Mathematics, University of Arizona, Tucson, AZ 85721, United States. mark.robertsontessi@moffitt.org
Journal of Theoretical Biology
|November 5, 2011
Summary
This study presents a mathematical model of tumor-immune interactions, identifying key immunosuppression factors like TGF-β and limited immune cell access. Optimal tumor antigenicity maximizes immune response, with implications for immunotherapy strategies.
Area of Science:
- Immunology
- Mathematical Biology
- Cancer Research
Background:
- Tumor growth involves complex interactions with the immune system.
- Understanding immune evasion mechanisms is crucial for effective cancer therapies.
Purpose of the Study:
- To develop a mathematical model simulating tumor-immune system dynamics.
- To identify key factors contributing to tumor immune escape.
- To explore the impact of tumor antigenicity and dendritic cell therapy.
Main Methods:
- Developed a mathematical model incorporating effector T cells, regulatory T cells, helper T cells, and dendritic cells.
- Included multiple immunosuppression mechanisms via cytokines and growth factors.
- Accounted for reduced immune cell access to larger tumors.
Main Results:
- Identified TGF-β-induced immunosuppression, regulatory T cell conversion, and limited immune cell access as critical for tumor escape.
- Determined an optimal tumor antigenicity exists for maximizing immune response.
- Simulations suggest an optimal dose for dendritic cell therapy in certain tumors.
Conclusions:
- Tumor immune escape is driven by specific immunosuppressive pathways and physical barriers.
- Tumor antigenicity plays a dual role, with an optimal level for immune control.
- Mathematical modeling provides insights into optimizing immunotherapies like dendritic cell transfer.
Related Concept Videos
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...

